Retiring Bioventus CEO Shares Thoughts on Orthobiologics Market

In early March, we interviewed former Bioventus CEO Anthony P. Bihl III on the state of the orthobiologics market and his vision for the future of Bioventus. Since then, COVID-19 has spread globally and Mr. Bihl announced his retirement, effective April 30. We believe that his perspective on the growth opportunities and headwinds in biologics...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Carolyn LaWell is ORTHOWORLD's Chief Content Officer. She joined ORTHOWORLD in 2012 to oversee its editorial and industry education. She previously served in editor roles at B2B magazines and newspapers.

Contact Us